Active, Not Recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037
- Conditions
- Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
- Locations
-
- Arizona Mayo Clinic Phoenix, Arizona, United States
- University of California at San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States